We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
SARS‐COV‐2 a trigger of myelin oligodendrocyte glycoprotein‐associated disorder.
- Authors
Johnsson, Magnus; Asztely, Fredrik; Hejnebo, Susanne; Axelsson, Markus; Malmeström, Clas; Olausson, Torbjörn; Lycke, Jan
- Abstract
SARS‐COV‐2 frequently cause neurological disorders and is sometimes associated with onset of autoimmune diseases affecting the nervous system. Over recent years, a rare but distinct diagnosis designated myelin oligodendrocyte glycoprotein‐associated disorder (MOGAD) has been recognized in patients with attacks of optic neuritis, myelitis, or encephalomyelitis and increased levels of anti‐MOG antibodies. The cause of MOGAD is unknown. However, there have been reports of single cases of MOGAD in patients with Covid‐19 infection. We report a series of SARS‐CoV‐2 positive patients that developed MOGAD, but a homology search did not support a cross‐reactive immune response to SARS‐CoV‐2 spike‐protein and MOG.
- Subjects
COVID-19; NEUROLOGICAL disorders; SARS-CoV-2; MYELIN; MYELITIS; OPTIC neuritis; NEUROMYELITIS optica
- Publication
Annals of Clinical & Translational Neurology, 2022, Vol 9, Issue 8, p1296
- ISSN
2328-9503
- Publication type
Article
- DOI
10.1002/acn3.51609